Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5699875 | Clinical Oncology | 2006 | 5 Pages |
Abstract
We found that the ICTP is not a superior serum marker for bone metastases compared with ALP or PSA. Our study suggests, however, that the ICTP measurement is useful in a certain subset of men with the combination of PSA and ALP in distinguishing men with bone metastasis from those without.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
A. Kataoka, T. Yuasa, S. Kageyama, N. Tsuchiya, T. Habuchi, H. Iwaki, M. Narita, Y. Okada, T. Yoshiki,